Win a $50,000 3D I/O Pro™ research grant from Alpenglow

Alpenglow Biosciences has developed the 3D I/O Pro™ assay to quantitatively assess tissue heterogeneity in the study of immuno-oncology, disease pathogenesis, and treatment response. To accelerate the development of novel therapeutics and next generation research in the important field of immuno-oncology, Alpenglow is launching a $50,000 research grant program, open to scientists worldwide, to leverage the 3D I/O Pro™ assay to unlock novel biological insights with 3D spatial biology.

Learn more about the research program and how the 3D I/O Pro™ assay can help accelerate your drug discovery and clinical programs.  3D I/O Pro™ assay is for Research Use Only (RUO).  Not for use in diagnostic procedures.